4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-230467
Chief Executive Officer sold 40,000 shares at an average $85.08 ($3,403,253)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-01 | Sale : show line 1 in the form 10b5-1 | −5,616 | $84.29 | $473,370 | 2,815,754 | I |
| 2025-10-01 | Sale : show line 2 in the form 10b5-1 | −31,190 | $85.16 | $2,656,265 | 2,784,564 | I |
| 2025-10-01 | Sale : show line 3 in the form 10b5-1 | −3,194 | $85.67 | $273,618 | 2,781,370 | I |
| Open-market sales · 40,000 sh · avg $85.08 · $3,403,253 | ||||||
Loading xslF345X05/ownership.xml…